How Much You Will Earn Through Indegene Limited IPO?
You will earn ₹8646 If you are allocated for Indegene Limited IPO.
| Description | Value |
|---|---|
| IPO Price Band | ₹430 to ₹452 |
| Cap Price of IPO | ₹452 |
| Latest GMP (Grey Market Premium) | ₹262 |
| Estimated Listing Price | ₹714 |
| Expected Gain per Share | ₹262 |
| Expected Percentage Gain | 57.96% |
| Lot Size | 33 shares |
| Total Expected Profit (per lot) | ₹8646 |
Calculation of Earning
Price Band ₹430 to ₹452 per shareSo mostly you will earn
Latest GMP of Indegene IPO last GMP is ₹262 With the price band of 452.00,
Listing Price will be = 452+262= ₹714
Indegene IPO’s estimated listing price is ₹714 (cap price + today’s GMP).The expected percentage gain/loss per share is 57.96%.
Profit Will be 262 * lot size
lot size =33 Shares
262 * 33 =₹8646
When your money will unblock incase you didn’t allocated IPO?
| Event | Date |
|---|---|
| Basis of Allotment Date | 9th May 2024 |
| Refunds Initiation | 10th May 2024 |
| Credit of Shares to Demat | 10th May 2024 |
| IPO Listing Date | 13th May 2024 |
Your money will unblock on Monday as it display 10th May 2024 but normally it is late so Money will be unblock on 13 May 2024.
Recommendation By Members Apply OR Not ?
| Member | Title/Status | Review Summary | Likes | Date & Time of Review |
|---|---|---|---|---|
| Chem cho | IPO Guru (2500+ Posts, 2700+ Likes) | Apply for Listing Gain at Cut-off Price. No peers to compare with. Advises weak hands to apply for listing gains and risk-takers to hold for a potential ₹100 above issue price. | 1 | May 6, 2024, 7:06:23 AM |
| ak jain | – | Requests information on stocks with subsidiaries coming up for IPOs, for the shareholder quota. | 0 | May 1, 2024, 12:25:52 AM |
| B.M.SURANA | IPO Guru (2600+ Posts, 4800+ Likes) | Suggests applying for Listing Gain at Upper Price Band. Recommends considering sale in GM subject to conditions. | 0 | April 29, 2024, 11:28:36 AM |
| parmod gupta | Top Contributor (300+ Posts, 300+ Likes) | Recommends applying for the long term at Cut-off Price due to strong fundamentals. Also suggests applying for listing gains. | 0 | – |
About Company
Sector:
Life Sciences Commercialization
Services:
Product Development & Market Launch: Helps biopharmaceutical, biotech, and medical device companies develop and market new products.
Technology Integration: Utilizes AI, machine learning, and natural language processing tailored for life sciences.
Data Analysis & Insights:
Enhances data literacy and analytics.
AI-driven monitoring and analysis of adverse events.
Risk mitigation and regulatory compliance.
Purpose:
To enable healthcare organizations to be future-ready.
Vision:
To be the trusted partner for healthcare organizations to improve health outcomes.
Operational Approach: